This virtual event is the second session in the upcoming series entitled "Intersecting Epidemics in the Context of Ending the Epidemic:  Tackling HIV, Substance Use, and HCV". This series is co-sponsored by the MidAtlantic AIDS Education and Training Center (MAAETC), the National Alliance for HIV Education and Workforce Development (NAHEWD), the Opioid Response Network (ORN), the Mid-Atlantic Regional Public Health Training Center, and the Central East Addiction Technology Transfer Center (ATTC).

The audience for this program is mixed- HIV providers, substance use disorder treatment programs, opioid treatment programs and others.

Session objectives:

By the end of the presentation, participants will be able to:
1. Discuss the latest treatment considerations for hepatitis C
2. Describe best practices for hepatitis C treatment in people with HIV and/or Substance Use Disorder

Session Schedule:

• 8:45am-9:00am - Welcome, Logistics, Introductions and Overview
• 9:00am-12:20pm - Didactic presentations and panel discussions

Faculty and Planning Committee Disclosures

James A. Ealy, MA. Ingrid Godfrey MPH Susan Thompson, BS and Kathleen Wolff, MSN, CRNP have no relationships to disclose

Joanne Gilmore, MSN, CRNP is on the HCV speaker’s bureaus of Gilead Sciences, Inc. and AbbVie. She will support her presentation and clinical recommendations with the "best available evidence" from the medical literature.